Micar Innovation (Micar21)
Micar Innovation is a drug discovery factory. The company has found a niche where it is able to create a large societal impact by improving the quality of life through new blockbuster drug molecules for a large class of diseases.
Micar Innovation focuses on non-clinical Proof-of-Concepts (POCs) in preclinical R&D and Hit-to-Lead (H2L) achievements in areas such as neuroscience, oncology, cardio-vascularity, dermatology, and rare diseases. Micar21 is our drug discovery platform for small-molecule drug candidates. The business model is based on licensing our intellectual property to commercial partners and on the creation of new spin-out companies.